HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Policy

IRA, state PBM reform, Medicare, and regulatory action

State PBM Legislation 2025-2026: National Chains Absorb, Independents Scramble
Policy
State PBM rules in 2025-2026 mean new six-figure legal and data costs for independents, while chains like CVS …
Mar 21, 2026
IRA Price Negotiation Year One: What the Numbers Reveal About CMS, Drugmakers, and the Real Deals
Policy
In its inaugural round, CMS demanded deep price cuts on blockbuster drugs under the IRA. Drugmakers pushed bac…
Feb 5, 2026
IRA Price Negotiation Year One: Who Blinked, Who Balked, and What's Next for Big Ticket Drugs
Policy
First-round IRA negotiations saw average price cut offers near 29 percent, but some manufacturers accepted con…
Jan 22, 2026
Part D Redesign Hits Manufacturers: The Catastrophic Coverage Math
Policy
The IRA Part D redesign shifts billions in catastrophic costs to manufacturers. Here is who gets hit hardest.…
Jan 20, 2025
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.